Results

In positive early studies of the VivoPlex product, the wireless power technology and data transmission were demonstrated successfully. In addition, the safety data was good, with no inflammatory response to the product indicating good biocompatibility.

Following on from this research, proof of concept in humans has been demonstrated with a prototype (temperature only) VivoPlex product. In the 15-patient study, it was safe, well tolerated, operational for up to three days, and data was successfully transmitted.

Further clinical studies are in development.

Human feasibility data

2015 study in 15 women for up to 3 days showed:
Safety and tolerability of a larger, temperature-only prototype.

Successful wireless power and data transmission.

Patterns of temperature variation and between patients merits further investigation.

Individual temperature data from 3 hours to 3 days

“Knowledge of what a healthy womb environment looks like, and how it might be different in infertility, will be invaluable for improving treatment outcomes. Although it is still in development, we believe our wireless device has the potential to transform this area of medicine.”

Professor Ying Cheong

Professor in Reproductive Medicine at the University of Southampton,
Director & Co-Founder of VivoPlex

“Knowledge of what a healthy womb environment looks like, and how it might be different in infertility, will be invaluable for improving treatment outcomes. Although it is still in development, we believe our wireless device has the potential to transform this area of medicine.”

Professor Ying Cheong

Professor in Reproductive Medicine at the University of Southampton,
Director & Co-Founder of VivoPlex

CONTACT US

+44 (0)2380 111 555
enquiries@vivoplex.com
University of Southampton
Science Park, Southampton
SO16 7NP, United Kingdom

SOCIAL

INFORMATION

Copyright © VivoPlex Ltd.